









Standpoint on the priority of TNTs and
CNTs as targeted drug delivery systems
Yasmin Ranjous, Géza Regdon Jr., Klára Pintye-Hódi and Tamás Sovány, t.sovany@pharm.u-szeged.hu
Conventional drug delivery systems have limitations according to their toxicity and poor solubility,
bioavailability, stability, and pharmacokinetics (PK). Here, we highlight the importance of
functionalized titanate nanotubes (TNTs) as targeted drug delivery systems. We discuss the differences in
the physicochemical properties of TNTs and carbon nanotubes (CNTs) and focus on the use of
functionalization to improve their characteristics. TNTs are promising materials for drug delivery
systems because of their superb properties compared with CNTs, such as their processability, wettability,
and biocompatibility. Functionalization improves nanoparticles (NPs) via their surface modification
and enables them to achieve the targeted therapy.
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Conventional drugs often have poor solubility, PK,
biopharmaceutical properties, and stability or
cause toxicity [1]. By contrast, nanotechnology-
based drug delivery systems can improve the
solubility, absorption, permeation, retention time,
and bioavailability of drug molecules in target
tissues, as well as improving their stability and,
therefore, enhancing the shelf-life and accept-
ability of drugs by increasing either their uptake
efficacy or patient compliance [2].
Nanosized delivery systems can be internal-
ized by cells more effectively compared with
micro-sized particles. In addition, NPs can be
formulated in various shapes, sizes, and com-
positions, and can be modified physicochemi-
cally and functionally to obtain specific
properties depending on the requirements of
both the drug molecule and the targeted organ
[1]. Nanotubes have an ideal inner diameter of
5–6 nm for loading with large biological1704 www.drugdiscoverytoday.commolecules, with a surface area five times higher
than that of other NPs. Furthermore, cell inter-
nalization is higher in the case of tubular NPs
compared with their spherical counterparts (H.P.
Kulkarni, PhD thesis, University of North Carolina
at Chapel Hill, 2008).
The first nanotubes to be discovered were
CNTs. The first synthesis method was
described by Lijima in 1991, whereas TNTs were
first synthesized by Hoyer via template-assisted
synthesis in 1996 (reviewed in Ref. [3]).
Nevertheless, over the past decades,
numerous synthesis routes with various
advantages and disadvantages have been
developed (Tables 1 and 2).
Structure and classification
Although both CNTs and TNTs have a tubular
structure, there are general differences in their
structure. CNTs are allotropes of carbon made
from graphene/graphite and are rolled up intoconcentric cylinders with various wall numbers,
on which their classification is based.
Single-walled CNTs (SWNTs) have a diameter
of 1 nm and length up to centimeters, prepared
by rolling a single graphene sheet to form a
cylinder. The conducting properties of SWNTs
depend on the wrapping nature [10], which is
represented by chiral vectors (n, m). A zigzag
structure is obtained when m = 0, an armchair is
obtained when n=m, and a chiral structure is
obtained when m lies between the zigzag and
the armchair structure values.
Although double-walled CNTs (DWNTs) gen-
erally have the same morphology and properties
as SWNTs [11], they also exhibit several advan-
tages, such as significantly improved resistance
to chemicals, the same thermal and electrical
stability as multiwalled CNTs (MWNTs), but the
same flexibility as SWNTs [12].
MWNTs have a diameter from 2 nm to 100 nm
and a length of tens of microns. They have two1359-6446/ã 2019 Elsevier Ltd. All rights reserved.
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TABLE 1
Comparison of CNT preparation methods
Method Product Advantages Disadvantages Refs
Arc discharge SWNTs 0.6–1.4 nm in diameter or;
MWNTs with 1–3 nm inner and
10 nm outer diameter
Upscalable for volume production;
nanotube diameter distribution can
vary; yield up to 90%
Solid graphite source required;
requires high temperature; SWNTs
only obtained with use of metal
[4]
Laser ablation SWNTs 1–2 nm in diameter and 5–
20 mm long, or fullerenes
High-quality nanotubes; yield up to
70%
Solid graphite source required; not
suitable for manufacture of MWNTs
because of short length
[5]
Chemical vapor deposition (CVD) SWNTs 0.6–4 nm in diameter or
MWNTs 10–240 nm in diameter
Distinguished configuration and
positional control
Two-step method; typical yield is
30%; often riddled with defects
[6]
Plasma-enhanced CVD SWNTs or MWNTs No solid graphite source required Complicated process [6]
Alcohol catalytic CVD SWNTs 1 nm in diameter SWNTs produced on large scale and
at low cost
Obstacles in creating high-purity
SWNTs
[6]
Hydrothermal Methods MWNTs with 10–100 nm inner and
50–150 nm outer diameter
nanorods, nanowires, nanobelts
and nano-onions
Starting materials stable at ambient
temperature; low temperature
(150–180 C) required; no
hydrocarbon or carrier gas required
[7]
TABLE 2
Comparison of TNT preparation methods
Method Advantages Disadvantages Refs
Electrochemical treatment Self-organized TNT layers with large (~100 nm)
diameter; suitable for surface modification of Ti
implants
Length varies (2–101 mm); not suitable for many
biomedical applications because of size and potential
clearance by reticuloendothelial system
[8]
Template-assisted synthesis Variable (50–400 nm) diameter based on template
pore size
[9]
Hydrothermal treatment Small (5–10 nm) diameter and 100–1000 nm length;
variable dimensions, porosity and specific surface
depending on temperature, NaOH concentration,
sonication and acidic post-treatment
Strongly agglomerated TNTs, which need to be
dispersed before bioapplication; nanosheets result as
byproducts (~10% of batch)
[8]
TNT MWCNT
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FIGURE 1
Schematic representation of the structural differences between titanate nanotubes (TNTs) and













structural models: the ‘Russian Doll’ model,
when graphite sheets are ordered in concentric
cylinders (Fig. 1), and the ‘Parchment’ model
[11], when a single sheet of graphite is rolled in
around itself. The layers have different chiralities
with inconsiderable interlayer electronic
coupling, and can shift randomly between
metallic and semiconducting varieties. The main
advantage of MWNTs is that their stiffness is
higher than that of SWNTs, especially during
compression [12]. The length-to-diameter ratio
of MWNTs is >1 000 000 given that they are
nanometers in diameter and several millimeters
in length [3].
By contrast, TNTs are rolled up into a spiral
(Fig. 1). with an inner cavity of~4 nm and have an
amorphous or crystalline structure depending
on the specific electrochemical parameters [8].
The TNTs obtained after anodization are amor-
phous and not photoactive, whereas high
temperature annealing converts amorphous
TNTs into a crystalline form (anatase or rutile)
and, hence, broadens their application range.
TNTs are classified according to the synthesis
parameters used to prepare TNTs, such as with
template-assisted synthesis, hydrothermal
treatments, or electrochemical treatments (H.P.Kulkarni, PhD thesis, University of North Carolina
at Chapel Hill, 2008), which cause variations in
their physical features (e.g., length, and inner
diameter and outer diameter distributions).
Comparison of the physicochemical
properties
CNTs have highly hydrophobic surfaces because
they preserve the apolar characteristics of native
graphene/graphite nanosheets and are
insoluble in aqueous solutions [13], where the
surface charge of CNTs is a function of the pH of
the solution [14]. However, their solubility can be
enhanced by functionalization [12], which can
also facilitate their movement in the body and
reduce both the blockage of body organpathways and toxicity, partially by hindering
the accumulation of highly apolar molecules in
tissue. Nevertheless, the grade of toxicity (in vivo
and in vitro) is determined by diverse factors,
such as size, shape, purity, surface chemistry,
and the existence of transition metal catalysts.
Furthermore, it appears that the effect of CNTs
on organs is related to the administration route
used [15]. Intravenous, oral, and dermal ad-
ministration of CNTs can cause only mild
symptoms, whereas inhalation can result in
severe inflammation and toxicity to the
respiratory system. By contrast, another study
reported that no significant lung inflammation
or tissue damage was observed following direct
inhalation of CNTs.www.drugdiscoverytoday.com 1705









By contrast, TNTs display strong hydrophilicity
because of their partially hydroxylated surface,
which causes a negative z-potential (after
washing until pH = 6) that, when combined with
hydrogen bonds, causes superior wettability
[16] but often leads to the agglomeration of the
particles, especially in dry forms [8]. Their
hydrophilicity is also supported by the
capillary effect, resulting in the quick penetra-
tion of water droplets into the tube pores, and
by their crystallinity, given that the amorphous,
mixed crystalline phase shows high polarity
because of the O–Ti–O bonds and to the ex-
tensive presence of hydroxyl groups on the TNT
surface. Furthermore, the structure of TNTs also
influences the contact angle, which decreases
with increases in both tube and pore diameters
and with increasing anodization voltage or
thermal treatment up to 450 C; however, be-
yond 450 C, their hydrophilicity decreases be-
cause of the detachment of hydroxyl groups
from the surface [17]. The high surface energy
and polarity causes good wettability and, hence,
improved cell adhesion. Therefore, TNTs showed
extremely good biocompatibility. Bone cell ad-
hesion and differentiation were improved by the
use of TNT-covered implants and were proven to
be better than those with a pure Ti surface. TNTs
were also nontoxic when internalized by cells
[18–20]; thus, they appear to have good appli-
cability for therapeutic use in the clinic [21].
Despite their different surface characteristics,
CNTs and TNTs exhibit considerable similarities
regarding their impressive mechanical, electri-
cal, and optical properties. Nanotubular struc-
tures usually have good mechanical properties.
In CNTs, the covalent bonds between carbon
atoms lead to high tensile strength (up to 63
GPa) and Young’s modulus of elasticity (1–1.8
TPa depending on the diameter and the chirality
of the tube) [3]. Therefore, SWNTs are stronger
than steel by 10 to 100 times per unit weight. By
contrast, MWNTs have lower Young’s modulus
values than SWNTs because stress is only sup-
ported by the outer graphite shelf on account of
weak intertube cohesion. Similarly, TNTs exhibit
high, but one grade lower Young’s modulus
(230 GPa) and tensile strength (680 MPa) com-
pared with SWNTs. Nevertheless, these values
still reflect impressive mechanical properties,
supported by the results of Sipos et al., who
reported that TNTs and their composites formed
with various drugs showed supreme flowability,
compressibility, and compactibility compared
with crystalline APIs, thus proving their superior
processability [22–24]. In terms of their electrical
behavior, CNTs display semiconducting or
metallic resistance, capacitance, and inductance1706 www.drugdiscoverytoday.comproperties because of their electronic structure
and symmetry of graphene [12]. SWNTs can be
either semiconducting or metallic, whereas
MWNTs are semiconducting. The electrical
conductivity of self-organized TNTs is based on
their crystalline structure and is tunable with the
annealing temperature, because when the
amorphous material converts into anatase at
300 C, it results in significantly higher con-
ductivity, whereas the conversion of anatase
into the more resistive rutile above 500 C
reduces the conductivity [25]. In terms of their
optical properties, both CNTs and TNTs show
optical absorbance: the absorbance of CNTs is in
near-infrared (NIR) zone [12], whereas TNTs
display wider photo absorption properties, al-
though not as good as TiO2 NPs. However, when
rare earth ions (Pr31, Er31, Nd31, and Yb31) were
intercalated into TNTs, higher photolumines-
cence emission was observed compared with
pristine Na-TNTs [26]. Overall, these remarkable
properties make CNTs and TNTs an ideal target
for a range of diagnostic, biomedical, or
pharmaceutical applications.
Applications
The high binding capacity and unique physi-
cochemical, especially electrical properties of
nanotubes can be well utilized in specific mol-
ecule recognition and other diagnostic appli-
cations. CNTs can be used as biosensors to
diagnose diseases, record the pulse and tem-
perature of a patient, and measure blood glu-
cose, or other biomolecules, such as H2O2,
organophosphate pesticides, or cancer markers,
in diagnosis and treatment [12,27–29]. In addi-
tion, their good biocompatibility and mechani-
cal properties also make nanotubular structures
suitable for tissue-engineering applications.
CNTs can improve the mechanical strength of
implanted catheters and, hence, reduce
thrombus formation in cardiovascular surgeries
[12]. CNT-coated polyurethane has high inter-
connected porosity, bioactivity, and nanostruc-
tured surface topography. Thus, CNTs can be
used as bioactive scaffolds in bone tissue en-
gineering and provide new properties, such as
electrical conductivity, to these scaffolds [30], or,
when filled with calcium, they can be used
directly as a bone substitute, with improved
mechanical properties because of their high
tensile strength [3]. Consequently, they can help
in directing cell growth [12]. Correspondingly,
TNT coatings on scaffolds reinforce cell growth
on the biodegradable photopolymer scaffolds
[31] and also promote bone formation by has-
tening osteoblast growth by 300–400% com-
pared with non-anodized Ti surfaces [32]. Thiseffect was further improved when TNTs were
coated with biocompatible polymer films com-
prising chitosan and poly(lactic-co-glycolic acid),
when superior osteoblast adhesion and cell
proliferation were achieved, compared with
uncoated TNTs [33].
Given their unique characteristics, such as
their hollow monolithic structure, nanoneedle
shape, considerable molecule-binding capacity
and versatile binding mechanisms, nanotubes
are also ideal carriers in other biomedical and
pharmaceutical applications. Two different
methods exist for binding: wrapping, when
drugs and biological molecules are attached to
the surface through functional groups; and fill-
ing, when drugs and biological molecules are
loaded inside CNTs [34].
CNTs display immunogenicity and devised
antibody responses linked to viral protein VP1 of
foot-and-mouth disease virus (FMDV), which
could be utilized for the stimulation of the
immune system [3]. The high RNA binding and
internalization capacity also make CNTs suitable
for cytoplasm or cell core targeting and valuable
as vectors to transfer genes and drugs into cells
to cure cancer and various genetic disorders
[35]. However, SWNTs are more useful compared
with MWNTs because of their 1D structure,
efficient drug-loading capacity, and large sur-
face area [36]. CNTs conjugated to small inter-
fering (si)RNA molecules were successful in
silencing the expression of CD4 cell surface
receptors and CXCR4 co-receptors, thus inhi-
biting the infection of T cells by HIV [37]. Drug-
embedded CNTs can also be utilized to kill
viruses in viral ulcers without antibody pro-
duction against the drug, because viruses
present no intrinsic immunogenicity for CNTs
[38]. CNTs can carry streptavidin and cyto-
chrome C into the cell cytoplasm via the en-
docytosis pathway [12] and showed high
selectivity to kill cancer cells after internaliza-
tion, achieved by hyperthermia because of their
thermal conductivity [39]. However, MWCTs are
more suitable than are SWCTs for thermal cancer
treatment given that MWNTs absorb NIR radia-
tion faster than do SWNTs [40].
Nevertheless, CNTs can be applied for drug
delivery and targeting without external stimu-
lation because the SWCNT-anticancer drug
complex increases blood circulation time, en-
hancing permeability and the retention effect by
tumor cells [41], as shown by the successful
delivery of amphotericin B [42], the successful
delivery and retention of polyphosphazene
platinum to the brain [43], the successful oral
administration of erythropoietin (EPO) [43] and
the slow release of cisplatin in an aqueous
Drug Discovery Today Volume 24, Number 9  September 2019 PERSPECTIVEenvironment to terminate the growth of human
lung cancer cells [44].
Based on their physicochemical properties,
TNTs offer fewer opportunities to attach drugs
or other molecules; however, based on their
unique properties, such as biocompatibility,
mechanical strength, and chemical resistivity,
they are proposed to be ideal materials for the
development of various medical implants and
devices. Thus, TNTs have so far been applied
mainly in dentistry, orthopedics, and cardio-
vascular surgery [45].
Functionalization of TNTs and CNTs
Functionalization is the attaching of appropriate
molecules to the nanostructure surface to
render them soluble in water, reduce toxicity,
increase biocompatibility [46], achieve targeted
drug delivery, obtain selective binding to the
desired epitope, achieve controlled drug release,
facilitate cellular internalization, enhance bio-
distribution, and improve biofluid circulation.
Many types of functionalization molecule have
been used, such as polyethylene glycol (PEG),TABLE 3
Functionalization possibilities of CNTs
Reagent(s) 
Nitric acid (HNO3) 
NH2(CH2CH2O)2–CH2CH2NH2




HNO3 and salicylaldehyde 
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Dopamine; Tris buffer; bone





Allyltriethoxysilane; propyltriethoxysilane Form stab






undecylphosphonic acid; EGF and BMP2
growth factors
Increasing
Gelatin-stabilized gold NPs Improve M
Chitosan Achieve spolyvinylpyrrolidone (PVP), cellulose,
polypeptides, dextran, and silica [2].
CNTs can be functionalized covalently or
noncovalently on the tips and side walls, al-
though CNT tips have a higher functionaliza-
tion affinity compared with the side walls [46].
Noncovalent functionalization, including Van
der Waals interactions, p–p interactions, and
hydrophobic interactions, causes minimal
damage to the CNT surface and maintains the
aromatic structure and, consequently, the
electronic characteristics of CNTs. However, the
disadvantage is that this kind of functionali-
zation is not appropriate for targeted drug
delivery applications because of the weak
forces formed [47]. By contrast, covalent func-
tionalization of CNTs can be achieved via oxi-
dizing them by strong acids, such as nitric and
sulfuric acids [48]. Hence, the forming of car-
boxylic acid groups because of the high neg-
ative charge increases the hydrophilicity, water
solubility, and biocompatibility of CNTs [49]. By
contrast, the disadvantage is that covalent
functionalization damages CNT side walls and,Aim of functionalization/grafting 
Carboxylic groups covered MWNTs; increase
NH2 covering of MWNTs; increase solubility; 
effects
Increase surface binding ability of DNA probe
Selective destruction of cancer cells labeled 
NIR-triggered cell death without harming re
Photothermal cancer treatment in mice by N
Reduce reaction step number and reaction t
)-3-
de;
Specific recognition of multidrug-resistant h
nctionalization/grafting 
bone osseointegration 
TNT dispersion in water and reactivity 
le suspensions in tetrahydrofuran (THF) 
rmation of biofilms (based on bactericide and bacter
initial attachment and proliferation of human mesenc
steogenic differentiation and pre-osteoblast adhesion
 number and activity of MSCs 
C3T3-E1 osteoblast cell adhesion and propagation (
ustained release of loaded drug (selenium or quercetthus, CNTs cannot be used in some applica-
tions, such as imaging [37]. Nevertheless, the
presence of carboxylic and other oxygen-
containing groups on the surface of CNTs also
allows the covalent attachment of functional
molecules [50]. The covalent surface functio-
nalization of CNTs with amine-terminated PEG
stabilizes CNT dispersions in various media and
reduces deleterious effects on cultured cells
[51], and oxidation debris (i.e., the breaking
CNTs during oxidation or oxidizing
carbonaceous nontubular structures in pristine
CNT samples).
Similarly, the surface characteristics, such as
the negative charge at physiological pH caused
by the presence of hydroxyl groups on their
surface above their isoelectric point (pH 3.7),
enable TNTs to react with a variety of functional
molecules [52]. The functionalization of TNTs
improves their stability for vectorization
applications and enables them to carry
therapeutic molecules [53]. Tables 3 and 4 detail
methods for the functionalization of CNTs and
TNTs, respectively.Refs
 solubility [54]
decrease aggregation; decrease cytotoxic [55]
 by supplying large number of amino groups [56]
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Drug delivery devices based on nanotubular
structures are ideal for modern theranostic
applications because of their advantageous
properties. However, they can bear the risk of
toxicity attributable to their size, surface
charge, chemical composition, chemical re-
activity, chemical structure, crystal structure,
shape, solubility, and degree of agglomera-
tion. Moreover, nanomaterials can cause oxi-
dative stress and damage phagocytosis inside
the cells, reduce cell viability, and suppress cell
proliferation by producing reactive oxygen
species or remaining in the body because of
their ability to evade the reticuloendothelial
system.
Despite many promising results and numer-
ous advantages, pristine CNTs are insoluble in
water and most solvents; thus, they cannot be
used immediately in biomedical applications.
Furthermore, they bear a considerable risk of
toxicity and carcinogenicity because they ac-
cumulate in the human body because of their
strongly hydrophobic nature and residual metal
catalysts, which increases their ability to pro-
duce O2 anions, lipid peroxidation, or physical
blockage generated from agglomeration at high
doses, given that CNTs also have a strong
electrostatic attraction.
By contrast, TNTs have exhibited promising
toxicological profiles and good biocompatibility
in numerous studies and a vital affinity for bone
cell adhesion and differentiation, which allows
their use in dentistry, orthopedics, and cardio-
vascular surgery. Therefore, and as a result of
their tubular structure, CNT-similar chemical
resistivity, mechanical strength, and electron
mobility, TNTs might be promising alternatives
for developing medical implants and devices.
Nevertheless, despite these advantages, TNTs,
especially hydrothermally synthetized free TNTs,
are poorly studied in terms of their use in drug
delivery applications, possibly because of their
hydrophilic nature, which improves their
biocompatibility and decreases the risk of ad-
verse effects, but also acts negatively on their
absorption and cell internalization properties.
Thus, functionalization might be key to im-
proving their applicability, given that the range
of possibilities is almost as wide as for CNTs.
Noncovalent bindings based on van der Waals
forces, hydrogen bonds or p–p interactions are
easily achievable, which maintain the aromatic
structure and electronic characteristics;
obtaining covalent functionalization with ether-
or esterification of the free surface -OH groups is
also possible. With the selection of the appro-
priate functional groups, the surface properties1708 www.drugdiscoverytoday.comand, therefore, their absorption and
internalization capacity could be improved
without the considerable elevation of the risk of
toxicity. Furthermore, their similar mechanical,
electrical, and optical parameters could provide
the same level of processability and range for
external stimuli-adjusted targeting possibilities
as CNTs.
In terms of their low toxicity and advanta-
geous physicochemical properties, the further
investigation, use, and application of hydro-
thermally synthetized TNTs is recommended for
the development of new advanced drug
delivery systems.
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